Page last updated: 2024-08-18

4-butyrolactone and Carcinoma, Pancreatic Ductal

4-butyrolactone has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Gao, W; Guan, D; Hu, Z; Lai, Y; Liu, M; Qi, C; Wang, J; Zhang, Y; Zhou, Q; Zhou, Y; Zhu, H	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Carcinoma, Pancreatic Ductal

Article	Year
Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells. Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22 Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pancreatic Neoplasms; Structure-Activity Relationship	2018

Article

Year

Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells.

Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22

Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pancreatic Neoplasms; Structure-Activity Relationship

2018